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Synopsis
Proline utilization A (PutA) is a bifunctional flavoenzyme with proline dehydrogenase (PRODH) and 1-pyrroline-5-
carboxylate (P5C) dehydrogenase (P5CDH) domains that catalyses the two-step oxidation of proline to glutamate.
Trifunctional PutAs also have an N-terminal ribbon–helix–helix (RHH) DNA-binding domain and moonlight as autogenous
transcriptional repressors of the put regulon. A unique property of trifunctional PutA is the ability to switch functions
from DNA-bound repressor to membrane-associated enzyme in response to cellular nutritional needs and proline
availability. In the present study, we attempt to construct a trifunctional PutA by fusing the RHH domain of Escherichia
coli PutA (EcRHH) to the bifunctional Rhodobacter capsulatus PutA (RcPutA) in order to explore the modular design
of functional switching in trifunctional PutAs. The EcRHH–RcPutA chimaera retains the catalytic properties of RcPutA
while acquiring the oligomeric state, quaternary structure and DNA-binding properties of EcPutA. Furthermore, the
EcRHH–RcPutA chimaera exhibits proline-induced lipid association, which is a fundamental characteristic of functional
switching. Unexpectedly, RcPutA lipid binding is also activated by proline, which shows for the first time that bifunctional
PutAs exhibit a limited form of functional switching. Altogether, these results suggest that the C-terminal domain
(CTD), which is conserved by trifunctional PutAs and certain bifunctional PutAs, is essential for functional switching
in trifunctional PutAs.
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INTRODUCTION
The proline catabolic pathway converts proline into glutamate
via two consecutive steps catalysed by proline dehydrogenase
(PRODH) and 1-pyrroline-5-carboxylate (P5C) dehydrogenase
(P5CDH) (Scheme 1). In the first reaction, PRODH forms the in-
termediate P5C through the flavin-dependent, two-electron oxid-
ation of proline. P5C then undergoes a non-enzymatic hydrolysis
step, forming glutamate-γ -semialdehyde (GSA), which is oxid-
ized to glutamate by NAD+ -dependent P5CDH. The reactions of
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proline catabolism affect a broad array of physiological processes
in different organisms [1–4] and have underlying roles in human
diseases such as cancer [5,6] and schizophrenia [7–9]. Proline is
also a critical respiratory substrate for Helicobacter pylori during
infection [10,11] and in the fungal pathogen, Cryptococcus neo-
formans, proline catabolism was previously shown to be required
for virulence in mice [12].
PRODH and P5CDH are separate enzymes in eukaryotes and
Gram-positive bacteria, whereas in Gram-negative bacteria the
enzymes are encoded as a bifunctional polypeptide known as pro-
line utilization A (PutA) [13,14]. In addition to catalytic activities,
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
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Scheme 1 Reactions catalysed by the bifunctional PutA enzyme.
The PRODH domain catalyses the oxidation of proline to P5C us-
ing a flavin cofactor as the electron acceptor. P5C undergoes
a non-enzymatic hydrolysis, resulting in GSA. The P5C dehydro-
genase domain (P5CDH) catalyses the NAD+ -dependent oxida-
tion of GSA to glutamate thereby generating NADH.
a subset of Gram-negative bacteria such as Escherichia coli and
Salmonella typhimurium encode PutAs with a DNA-binding do-
main, which allows PutA to repress transcription of putA and putP
(proline transporter) genes [15,16]. The DNA-binding domain in
trifunctional PutA provides a unique coupling between proline
availability and proline metabolic gene expression [15,16].
In S. typhimurium and E. coli, trifunctional PutA switches from
a DNA-bound transcriptional repressor to a membrane-bound en-
zyme based on intracellular proline levels and the redox state of
the flavin cofactor [16–18]. This change in intracellular location
and molecular function, known as functional switching, enables
bacteria to utilize environmental proline as a fuel source [19].
Proline reduction of the flavin cofactor significantly increases
PutA membrane binding affinity while diminishing PutA–DNA
binding affinity by only 2-fold [18,20–23]. The DNA-binding
domain of trifunctional PutAs is located at the N-terminus and
has been shown by X-ray crystallography to have the ribbon–
helix–helix (RHH) fold [15,24,25]. In contrast, the location of
the membrane-binding domain of PutA is an active area of re-
search. Previous studies of E. coli PutA (EcPutA) have iden-
tified conformational changes in the flavin cofactor and active
site residues of the PRODH domain that are critical for mediat-
ing redox activation of PutA membrane interactions [19,26,27].
Additionally, proline-dependent conformational changes occur
outside the PRODH domain that correlate with increased PutA
membrane binding [21]. These studies implicate a helical domain
near the PRODH active site in mediating membrane association,
but how conformational changes in PutA enhance membrane in-
teractions remains unclear.
The PutA protein family comprises three basic domain archi-
tectures [28,29]. Type A PutAs are approximately 1000 residues
in length and have the minimal set of domains needed for the two
catalytic activities. The crystal structures of the type A PutAs
from Bradyrhizobium japonicum [30] and Geobacter sulfurre-
ducens [31] have revealed the structural basis of PutA catalytic
activity including a tunnel between the PRODH and P5CDH do-
mains for channelling the P5C/GSA intermediate. Sequence ana-
lysis suggests that the catalytic core observed in these structures
is highly conserved throughout the entire PutA family. Type B
PutAs are larger (1100–1200 residues) and have a 100–200 C-
terminal domain (CTD) in addition to the catalytic core. We
recently showed that the CTD of the type B PutA from Rhodobac-
ter capsulatus (RcPutA) contributes to aldehyde dehydrogenase
activity and substrate channelling [29]. Type C PutAs (approx-
imately 1300 residues) have both the CTD and the RHH domain;
all trifunctional PutAs have the type C architecture.
The aim of the present study was to investigate the modularity
of PutA domain architectures by converting a type B PutA into a
type C PutA using protein engineering. The RHH DNA-binding
domain of EcPutA (EcRHH) was fused to the N-terminus of
RcPutA to create the chimaeric protein EcRHH–RcPutA (Fig-
ure 1). RcPutA and EcPutA are 47% identical (61% similar),
making RcPutA a suitable candidate for studying the effects of
adding an N-terminal RHH domain. We show that the addition
of the EcRHH domain to RcPutA generates a chimaeric protein
that resembles trifunctional EcPutA in terms of oligomeric state,




Unless noted, all chemicals were purchased from Sigma–Aldrich
or Thermo Fisher Scientific. Nanopure water was used in all
experiments.
Expression constructs and protein purification
A chimaera consisting of the RHH domain of EcPutA
(EcRHH, residues 1–52) fused to the N-terminus of RcPutA
was engineered. The EcRHH–RcPutA enzyme construct was
made by PCR amplification of the DNA-binding domain
(residues 1–52) of EcPutA using a pET14b-EcPutA con-
struct described previously [32]. NdeI restriction sites were
incorporated at both ends of the PCR product using primers
5′-CGGCGCCATATGATGACCGACCTTTCCGCCCTTGG-3′
and 5′-CGCCGCCATATGCTCCGGCAGAGTATCGCTGT-
TTTCC-3′. The PCR product was then inserted into the
previously made pET28a-RcPutA [29] construct immediately
upstream of RcPutA gene (NdeI). The resulting pET28-EcRHH-
RcPutA construct contained an amino acid linker between
EcRHH and RcPutA and was confirmed by DNA sequencing
(Eurofins MWG Operon).
EcPutA was overexpressed and purified as described previ-
ously [22,33]. RcPutA (1127 amino acids) and EcRHH–RcPutA
(1180 amino acids), both in a pET28a vector, were overex-
pressed in BL21(DE3) pLysS cells (Promega). Starter cultures
(5 ml) were grown overnight in LB medium (25 μg/ml kana-
mycin, 34 μg/ml chloramphenicol) and used to inoculate 4 litre
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Figure 1 Domain organization maps of EcPutA, R. capsulatus PutA (RcPutA) and EcRHH–RcPutA
In EcRHH–RcPutA, the RHH DNA-binding domain of EcPutA was fused to the N-terminus of R. capsulatus PutA. Numbers
below the domain map indicate amino acid position. L1 and L2 indicate inter-domain linkers.
cultures of LB medium plus antibiotics. Once cultures reached
absorbance at 600 nm (A600) of 0.8, 0.5 mM IPTG was added,
and cultures were grown overnight at 20 ◦C before harvesting by
centrifugation at 16 800 g for 30 min and freezing the cell pellets
at − 80 ◦C.
The frozen cell pellets were resuspended in 50 ml binding buf-
fer (20 mM Tris-base, 0.5 M NaCl, 5 mM imidazole, 10% gly-
cerol, pH 7.9) at 4 ◦C containing FAD (0.1 mM) and protease in-
hibitors ε-amino-N-caproic acid (3 mM), phenylmethylsulfonyl
fluoride (0.3 mM), leupeptin (1 μM), tosyl phenylalanyl chloro-
methyl ketone (48 μM) and tosyllysine chloromethyl ketone hy-
drochloride (78 μM). Cells were disrupted by sonication at 4 ◦C.
The solubility of the proteins was optimized by adding 0.25 mM
Triton X-100 to the cell lysate and incubating at 4 ◦C with slow
stirring for 30 min. The cell lysate was centrifuged for 1 h at
45 980 g in a JA-20 rotor (Beckman). The supernatant was then
filtered (0.2 μm filter, VWR) and loaded on to a Ni-NTA Super-
flow affinity column (Qiagen) equilibrated with Tris-base bind-
ing buffer (pH 7.9). Wash buffer (60 mM imidazole) followed
by elution buffer (500 mM imidazole) were then applied to the
column. Elution fractions containing PutA protein were dialysed
overnight at 4 ◦C into 50 mM Tris (pH 7.5) buffer containing
10 mM NaCl, 0.5 mM EDTA and 10% glycerol. The protein
was then loaded on to an anion exchange column (HiTrap Q
HP column, GE Life Sciences) equilibrated with the Tris buffer
above. A linear gradient of 0–1 M NaCl in Tris buffer (pH 7.5,
0.5 mM EDTA, 10% glycerol) was used to elute PutA. Purified
RcPutA and EcRHH–RcPutA were then dialysed into 50 mM
Tris (pH 7.5) containing 50 mM NaCl, 0.5 mM EDTA and 10%
glycerol and stored at − 80 ◦C. Protein purity was analysed by
SDS/PAGE. Protein concentration was determined by the 660 nm
Protein Assay (Thermo Scientific) using BSA as the standard. The
amount of bound FAD cofactor in purified RcPutA and EcRHH–
RcPutA was determined as previously described [17]. The N-
terminal hexahistidine tag was retained after purification.
PRODH kinetic assays
All steady-state assays were performed at 23 ◦C. Kinetic paramet-
ers for proline were determined using coenzyme Q1 (CoQ1) as an
electron acceptor and monitoring CoQ1 reduction by the decrease
in absorbance at 278 nm (ε = 14500 M− 1 cm− 1) [33]. Km and
kcat for proline were determined for RcPutA and EcRHH–RcPutA
(0.25 μM) by varying proline (0–100 mM) and fixing CoQ1 at
300 μM. Likewise, the Km and kcat for CoQ1 were determined
by varying CoQ1 (10–450 μM) while holding proline constant at
200 mM. The above assays were conducted in 50 mM potassium
phosphate (pH 7.5) and 25 mM NaCl. Data were collected using a
0.15 cm path length on a Hi-Tech Scientific SF-61DX2 stopped-
flow instrument. Kinetic parameters were determined by fitting
initial velocities to the Michaelis–Menten equation (SigmaPlot
12.0) [34].
PRODH–P5CDH coupled assay
PRODH–P5CDH coupled activity, in which proline is converted
to glutamate, was measured as described previously [30]. Briefly,
0.25 μM enzyme was mixed with 200 μM CoQ1, 40 mM proline
and 200 μM NAD+ in 50 mM potassium phosphate (pH 7.5)
containing 25 mM NaCl. The progress of the reaction was fol-
lowed by NAD+ reduction at 340 nm (ε340 = 6200 M− 1 cm− 1).
Oligomeric structure determination
The oligomeric states of RcPutA and EcRHH–RcPutA were de-
termined by gel filtration chromatography and sedimentation
equilibrium. The purified proteins were loaded on to a Super-
dex 200 10/300 GL column (GE Life Sciences) and eluted by
FPLC in 50 mM Tris buffer (pH 7.5) containing 100 mM NaCl,
0.5 mM EDTA and 10% glycerol at a flow rate of 0.5 ml/min. The
molecular mass (M) of each protein was estimated using thyro-
globulin (669 kDa), apoferritin (443 kDa), β-amylase (200 kDa),
BSA (66 kDa) and carbonic anhydrase (29 kDa) as molecular
mass standards.
Sedimentation equilibrium was performed using an Optima
XL-I analytical ultracentrifuge (Beckman Coulter) equipped with
an eight-hole An50 Ti rotor. EcRHH–RcPutA (2 mg/ml) was dia-
lysed in 50 mM Tris buffer (pH 7.5) containing 100 mM NaCl,
0.5 mM EDTA and 5% glycerol. The dialysed EcRHH–RcPutA
protein was then diluted to three concentrations of 0.2, 0.5 and
0.8 mg/ml, and loaded at 110 μl each into the sample cells. The
reference cell was loaded (125 μl) with the dialysate buffer.
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Radial absorbance scans with a spacing of 0.001 cm were collec-
ted at 280 nm for each concentration of EcRHH–RcPutA at 22 h
and 24 h after equilibration at 8000 rpm. The scans are an average
of ten measurements at each radial position. Origin 6.0 software
was used to best-fit the data to a single ideal species model us-
ing a solvent density of 1.018 g/ml and a partial specific volume
of 0.742 ml/g estimated from the EcRHH–RcPutA sequence by
Sednterp software.
SAXS
For SAXS experiments, EcRHH–RcPutA was expressed as de-
scribed above and then purified according to the following pro-
tocol. Frozen cells were thawed in the presence of 1 mM phenyl-
methylsulfonyl fluoride and 20 mM N-octyl-β-D-glucoside at
4 ◦C. The resulting cell paste was sonicated on ice for 1–2 min and
centrifuged at 26 892 g for 45 min using a SS-34 rotor. The super-
natant was transferred into new tubes and centrifuged at 32 539 g
for 45 min. The resulting clear supernatant was loaded on to a
Ni2 + affinity column (HisTrap HP, GE Healthcare) and EcRHH–
RcPutA was eluted using 300 mM imidazole. Samples containing
the enzyme were pooled and dialysed overnight against 50 mM
Tris/HCl, pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM tris(3-
hydroxypropyl)phosphine (THP) and 50 μM FAD. The dialysed
protein was loaded on to an anion exchange column (HiTrap Q,
GE Healthcare) and the column was eluted using a linear gradi-
ent of 0–1 M NaCl. Based upon the purity of samples as judged
by SDS/PAGE, the appropriate samples were combined and dia-
lysed against 100 mM Tris/HCl, 200 mM NaCl, 0.5 mM THP
and 1 mM EDTA at pH7.5. The protein was concentrated to ap-
proximately 20 mg/ml using a 30 000 kDa cutoff membrane; the
protein concentration was measured using the Bradford method.
Size exclusion chromatography was performed using a Superdex
200 column equilibrated in 50 mM Tris, 200 mM NaCl, 0.5 mM
THP at pH7.5. The protein concentration after size exclusion
chromatography was in the range 8–12 mg/ml.
SAXS data were collected at beamline 12.3.1 of the Advanced
Light Source through the mail-in program [35,36]. The protein
was shipped via overnight courier to the beamline in a 96-well
plate that was kept 4 ◦C. For each protein fraction, scattering in-
tensities were measured at three nominal protein concentrations.
For each protein concentration, exposure times of 0.5, 1.0, 3.0
and 6.0 s were used. Scattering curves collected from the protein
samples were corrected for background scattering using intensity
data collected from the effluent from size exclusion chromato-
graphy.
The SAXS data were processed as follows. A composite scat-
tering curve for each sample was generated with PRIMUS [37]
by scaling and merging the high q region from the 3.0 s exposure
with the low q region from the 0.5 s exposure. The scattering
curves were multiplied with a concentration factor and overlaid
on each other to check for concentration dependent variation of
the profile. No substantial concentration effects were observed.
Structural properties were derived from the merged SAXS
profile as follows. The radius of gyration (Rg) was determ-
ined from Guinier analysis using PRIMUS. GNOM [38] and
SCATTER were used to calculate pair distribution functions in
order to estimate the maximum particle dimension (Dmax) and real
space Rg. The M was estimated from the SAXS volume of correl-
ation (Vc) [39] as described previously [40]. Shape reconstruction
calculations were performed with GASBOR using Dmax of 183
˚A (1 ˚A = 0.1 nm) and 2-fold symmetry. Thirty-two independent
GASBOR models were generated and then averaged and filtered
using DAMAVER [41]. The Situs module pdb2vol was used to
convert the averaged, filtered models into volumetric maps [42].
SUPCOMB was used to superimpose dummy atom models [43].
The SAXS curve and GNOM file used for the analysis described
here have been deposited in the Small-angle Scattering Biological
Data Bank (SASBDB) under the accession code SASDB27 [44].
DNA-binding
DNA-binding activity was determined by gel mobility shift as-
says using fluorescently labelled put control DNA from E. coli as
previously described [24]. A dissociation constant of EcRHH–
RcPutA with put control DNA was determined by best-fit analysis
to eqn (1) (Sigma Plot 12), where n is the number of binding sites
and [L] is total concentration of protein [17].
Fraction of DNA Bound =n [L] /(Kd+ [L] ) (1)
Lipid pull-down assays
Lipid pull-down assays were performed anaerobically under a
nitrogen atmosphere in an anaerobic chamber (Belle Technology
Glovebox) as described previously using E. coli polar lipids (Av-
anti Polar Lipids) [26]. In these assays, 50 mM proline was used
to reduce the flavin cofactor in the PutA proteins (0.3 mg/ml)
during the incubation with lipid vesicles.
RESULTS
General properties and steady-state kinetic
parameters of EcRHH–RcPutA
EcRHH–RcPutA was expressed as a soluble protein in E. coli and
has a molecular size on SDS/PAGE consistent with the predicted
M of 126 kDa. The UV–visible spectrum of EcRHH–RcPutA
has absorbance maxima at 380 nm and 451 nm showing incor-
poration of flavin into the protein fold. The flavin absorbance
spectrum indicates 92% flavin content. The incorporation of one
FAD per protein monomer is consistent with previous and recent
studies of RcPutA [29] and other PutAs [17,30,31].
The PRODH steady-state kinetic parameters of EcRHH–
RcPutA were determined for comparison to those previously
reported for RcPutA (Table 1). The Km and kcat values for proline
as the variable substrate are 5.3 mM and 0.89 s− 1, which are
close to those of RcPutA (5.6 mM and 1.0 s− 1). The catalytic
efficiencies of the chimaera and RcPutA differ by just 6%. Using
CoQ1 as the variable substrate, the parameters are Km of 161 μM
and kcat of 1.1 s− 1. These values are within a factor of two of
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Table 1 PRODH kinetic parameters for EcRHH–RcPutA and RcPutA
Proline CoQ1
Enzyme Km (mM) kcat (s−1) kcat/Km (M−1 s−1) Km (μM) kcat (s−1) kcat/Km (M−1 s−1)
EcRHH–RcPutA 5.3 +− 0.9 0.89 +− 0.1 167.9 +− 5.2 161.0 +− 15.8 1.1 +− 0.1 6832 +− 715
RcPutA 5.6 +− 0.8 1.0 +− 0.1 178.6 +− 30 93.7 +− 19.0 2.0 +− 0.1 21505 +− 4579
Kinetic parameters were determined in 50 mM potassium phosphate, 25 mM NaCl, pH 7.5. Data obtained from Luo et al. [29].
Table 2 Structural parameters of EcRHH–RcPutA
Parameters
M from AUC (kDa)* 256
M from SAXS (kDa) 220
Guinier Rg (A˚) 51 +− 1
Real space Rg (A˚) 53–56
Vc (A˚2) 1187
Porod volume (A˚3) 383000
Oligomeric state dimer
The M estimated from equilibrium analytical ultracentrifugation. The M estimated from
M= Vc2RG − 1/0.1231.
those of RcPutA. These results show that fusing the EcPutA RHH
domain on to RcPutA does not significantly affect the PRODH
kinetic parameters.
Coupled PRODH–P5CDH assays were performed to further
explore the kinetic properties of EcRHH–RcPutA. These assays
report on the activity of both the PRODH and P5CDH active sites
by monitoring NADH formation, which is used as a read out of
the overall conversion of proline to glutamate. Figure 2 shows the
results of PRODH–P5CDH coupled assays for EcRHH–RcPutA
and RcPutA conducted under identical conditions. The steady-
state velocity of NADH formation for EcRHH–RcPutA is similar
to that of RcPutA, thus providing additional evidence that the
fusion of the EcPutA DNA-binding domain does not disrupt the
overall kinetic properties of RcPutA. In addition, no lag phase
is apparent in these assays suggesting that the intermediate L-
P5C/GSA does not equilibrate with bulk solvent but instead is
channelled between the PRODH and P5CDH active sites [30].
These results are consistent with that previously described for
other PutAs [29–31, 45].
Oligomeric state determination
The domain organization of RcPutA provides an excellent op-
portunity to explore the impact of the RHH and CTDs on the
oligomeric organization of PutAs. Previous studies have shown
that the RHH domain mediates dimerization of EcPutA [46]. In
contrast, RcPutA is monomeric [29], which is consistent with
RcPutA lacking the RHH domain of trifunctional PutA. The oli-
gomeric state of EcRHH–RcPutA was therefore determined to
see whether fusion of the RHH domain converts RcPutA into a
dimeric protein.
EcRHH–RcPutA and RcPutA were first analysed by gel fil-
tration chromatography. Figure 3(A) shows a striking difference
Figure 2 Coupled PRODH–P5CDH activity of EcRHH–RcPutA
The assay was performed using 200 μM CoQ1, 40 mM proline,
0.25 μM EcRHH–RcPutA in 50 mM potassium phosphate (pH 7.5) and
25 mM NaCl. NADH formation was monitored at 340 nm. For compar-
ison, a trace of RcPutA activity is also shown from a channelling assay
performed under identical conditions [29].
between the two proteins. The elution profile of EcRHH–RcPutA
estimates an M of approximately 315 kDa whereas RcPutA elutes
at an apparent M of approximately 122 kDa consistent with that
reported recently for RcPutA [29]. These results indicate that
EcRHH–RcPutA forms a higher order oligomer.
EcRHH–RcPutA was also analysed by analytical ultracentrifu-
gation. Sedimentation equilibrium experiments were performed
at three protein concentrations. The equilibrium data for EcRHH–
RcPutA (Figure 3B) were fit to an ideal single-species model,
which yielded an M value of 256 kDa (Table 2). These results
further show that EcRHH–RcPutA is a dimer (theoretic dimer M
of 251 kDa). Thus, fusion of the EcPutA RHH domain induces
dimerization of RcPutA.
SAXS analysis of EcRHH–RcPutA
EcRHH–RcPutA was analysed by SAXS, which can determine
solution structural properties of proteins such the Rg, Dmax, M and
molecular shape envelope [47,48]. A SAXS curve for EcRHH–
RcPutA is shown in Figure 4(A). The Guinier plots calculated
from data collected at three protein concentrations exhibit good
linearity (Figure 4A) and yield Rg values of 49.5–51.9 with an
average of Rg = 51 +− 1 ˚A (Table 2). Calculations of the pair dis-
tribution function (P(r)) suggest Rg of 53–56 ˚A for assumed Dmax
of 170–210 ˚A (Figure 4B). For comparison, the Rg and Dmax of
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Figure 3 Oligomeric structure analysis of EcRHH–RcPutA
(A) Gel filtration elution profiles (monitored at 280 nm) of RcPutA (solid
trace) and EcRHH–RcPutA (dotted trace). (B) Sedimentation equilibrium
analysis of EcRHH–RcPutA. The curves represent global fit analysis of
data from 0.2 mg/ml (circles), 0.5 mg/ml (squares) and 0.8 mg/ml
(diamonds) EcRHH–RcPutA at 8000 rpm to an ideal single-species
model yielding a 256 kDa species (theoretical 251 kDa). A vertical off-
set was applied to the residuals that are shown for each fit in the bottom
panel. M values are reported at a 95% confidence interval.
RcPutA are only 32 ˚A and 107 ˚A respectively [29], whereas those
of full-length EcPutA are 63 ˚A and 205 ˚A [46]. The P(r) curve
for EcRHH–RcPutA exhibits a major peak at r = 42 ˚A with a
shoulder on the high r side of the major peak. This distribution of
interatomic vectors resembles that of EcPutA (Figure 4B) and is
characteristic of a particle having two spatially separated lobes. In
contrast, the P(r) curve for RcPutA is monomodal with maximum
at r = 37 ˚A (Figure 4B). These results show that EcRHH–RcPutA
resembles EcPutA in terms of overall particle size and shape.
The M, and hence oligomeric state, of EcRHH–RcPutA was
determined from the SAXS data using the Vc method [39] and
Porod–Debye analysis [49] (Table 2). The SAXS Vc is estimated
to be 1187 ˚A2, which corresponds to M of 220 kDa. This value
is within 12% of the expected M of the EcRHH–RcPutA dimer
Figure 4 SAXS analysis of EcRHH–RcPutA
(A) Experimental SAXS curve and Guinier analysis (inset). The Guinier
plot spans the range of qRg = 0.584–1.31. The linear fit of the Guinier
plot has R2 of 0.9992. (B) P(r) curves for EcRHH–RcPutA for assumed
Dmax values of 170–210 A˚. The P(r) curves for RcPutA [29] and EcPutA
[46] are shown for reference.
(251 kDa) as described above. The estimated Porod volume is
383000 ˚A3. The assumption of a dimeric protein leads to a pro-
tein density of 1.1 g/ml, which is well within the characteristic
range for proteins of 0.9–1.5 g/ml [49]. In contrast, the assump-
tion of a monomeric or trimeric protein results in density values
of 0.54 g/ml or 1.6 g/ml respectively, which are unrealistic for
a compact folded protein. Thus, the SAXS data for EcRHH–
RcPutA are consistent with a dimeric protein.
SAXS shape reconstruction calculations were performed so
that the molecular shape of EcRHH–RcPutA could be compared
with those of RcPutA and EcPutA. The averaged and filtered
model for EcRHH–RcPutA resulting from 32 independent
calculations has a normalized spatial discrepancy of 1.7 +− 0.2
with only two discarded models, which indicates that the
ensemble is structurally homogeneous. EcRHH–RcPutA forms a
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Figure 5 SAXS shape reconstructions
(A) The envelope of EcRHH–RcPutA calculated from 32 independent
GASBOR shape reconstruction calculations performed with the assump-
tion of 2-fold symmetry. The normalized spatial discrepancy of the en-
semble is 1.7 +− 0.2. (B) The SAXS envelope of EcPutA. Reproduced
from [46]: Singh, R.K., Larson, J.D., Zhu, W., Rambo, R.P., Hura, G.L.,
Becker, D.F. and Tanner, J.J. (2011) Small-angle X-ray scattering studies
of the oligomeric state and quaternary structure of the trifunctional pro-
line utilization A (PutA) flavoprotein from Escherichia coli. J. Biol. Chem.
286, 43144–43153. (C) The SAXS envelope of RcPutA. Reproduced
from [29]: Luo, M., Christgen, S., Sanyal, N., Arentson, B.W., Becker,
D.F. and Tanner, J.J. (2014) Evidence that the C-terminal domain of a
Type B PutA protein contributes to aldehyde dehydrogenase activity and
substrate channeling. Biochemistry 53, 5661–5673. (D) Orthogonal
V-shaped dimer in solution with dimensions of 183 × 80 × 69 ˚A
(Figure 5A). EcPutA also forms a V-shaped dimer in solution
and has dimensions comparable with those of EcRHH–RcPutA
(205 × 85 × 55 ˚A, Figure 5B). Thus, EcRHH–RcPutA and
EcPutA have the same basic size and shape. Note that this shape
differs dramatically from the monomeric ellipsoid of RcPutA
(Figure 5C).
Previous studies on EcPutA have shown that the catalytic
domains reside in the two large outer lobes, whereas the RHH
dimer occupies the connector between the two lobes (Figure 5B)
[46]. This quaternary structure and domain arrangement appears
to be present in EcRHH–RcPutA. For example, the outer lobes
of the shape reconstruction of EcRHH–RcPutA are similar in
size and shape to the SAXS envelope of RcPutA (Figure 5D).
Furthermore, the connecting section between the two lobes
is large enough to accommodate the RHH dimer of EcPutA
(Figure 5D). It is concluded that fusion of the RHH domain
endows RcPutA with the oligomeric state, quaternary structure
and overall shape of EcPutA.
DNA-binding and lipid-binding of EcRHH–RcPutA
From the analysis above, it appears EcRHH–RcPutA adopts a
similar oligomeric state and spatial arrangement of the DNA-
binding and catalytic domains as that of EcPutA. We next sought
to determine if EcRHH–RcPutA exhibited the functional switch-
ing properties of EcPutA. The DNA-binding activities of EcPutA,
RcPutA and EcRHH–RcPutA were compared using gel mobility
shift DNA-binding assays. Figure 6(A) shows that RcPutA does
not bind DNA, as expected, whereas EcRHH–RcPutA binds put
control DNA similarly to EcPutA. A dissociation constant (Kd)
for EcRHH–RcPutA with put control DNA was determined by
varying EcRHH–RcPutA concentration in the binding assays as
shown in Figure 6(B). Figure 6(C) shows a plot of the fraction
of bound DNA compared with EcRHH–RcPutA concentration
fit to eqn (1) (n = 1.2), from which a Kd value of 58 +− 20 nM
was estimated. This value is nearly the same as that determined
previously for EcPutA (Kd = 45 nM) [17].
Lipid pull-down assays were used to test whether the mem-
brane binding properties of RcPutA and EcRHH–RcPutA are
regulated by proline reduction of the flavin cofactor as observed
for EcPutA [22,26]. RcPutA, EcRHH–RcPutA and EcPutA were
incubated with E. coli polar lipid vesicles in the absence and
presence of 50 mM proline. After incubation for 1 h, the soluble
views of a model of the EcRHH–RcPutA dimer. The shape reconstruc-
tions of EcRHH–RcPutA and RcPutA are shown as white mesh and
green surfaces respectively. The EcPutA RHH dimer (PDB code: 2GPE)
is shown as a grey surface with the DNA-binding surface highlighted in
red. This model was created by first fitting the RcPutA envelopes into
the shape reconstruction of EcRHH–RcPutA using the Fit-in-Map option
of chimaera [53]. Then, the EcPutA RHH dimer was manually docked
into the remaining open space so that the molecular 2-fold axis of the
RHH dimer is parallel to the 2-fold axis of the EcRHH–RcPutA envel-
ope. This model is consistent with previous SAXS modelling studies of
EcPutA [46].
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
7
B.W. Arentson and others
Figure 6 DNA-binding assays
(A) Gel mobility shift assays of EcPutA (200 nM), RcPutA (200 nM) and
EcRHH–RcPutA (200 nM) added to binding mixtures containing 3 nM
of fluorescent labelled (IRdye-700 label) put control DNA (420 bp) and
100 μg/ml of nonspecific calf thymus DNA. Free DNA and PutA–DNA
complexes were separated on a non-denaturing 4% polyacrylamide gel.
(B) Representative gel mobility shift assay with increasing concentra-
tions of EcRHH–RcPutA (0–400 nM) with fluorescently labelled put con-
trol DNA (3 nM). (C) Plot of EcRHH–RcPutA concentration compared with
fraction of DNA bound from two independent gel-shift assays. Data were
fit to eqn (1) to yield a dissociation constant (Kd) of 58 +− 20 nM.
and lipid fractions were separated by centrifugation and analysed
by SDS/PAGE to monitor PutA partitioning in the soluble and
lipid fractions. Figure 7 clearly shows that in the absence of
proline (i.e. oxidized state) RcPutA and EcRHH–RcPutA are
mainly in the soluble fraction similar to EcPutA. In the presence
of proline, RcPutA and EcRHH–RcPutA significantly partition
into the lipid fraction, indicating that membrane interactions
are favoured in a reducing environment as seen previously
with EcPutA [26]. These results indicate that RcPutA- and
EcRHH–RcPutA-membrane associations are redox regulated
similarly to that of EcPutA [19].
Figure 7 Lipid pull-down assays
EcPutA, RcPutA and EcRHH–RcPutA (0.3 mg/ml each) were incubated
with or without proline in HEPES buffer (pH 7.5, 150 mM NaCl) with
freshly prepared E. coli polar lipid vesicles (0.8 mg/ml) for 1 h at room
temperature. Following incubation, soluble and lipid fractions were sep-
arated by Airfuge ultracentrifugation and analysed via SDS/PAGE.
DISSCUSSION
Fusing the EcRHH domain to RcPutA generated a stable
EcRHH–RcPutA dimer providing evidence that dimerization in
trifunctional PutAs is mediated through the DNA-binding do-
main [24,46]. Kinetic assays showed that the dimeric structure
of EcRHH–RcPutA does not affect the catalytic properties of
RcPutA. The PRODH activity of EcRHH–RcPutA is similar
to RcPutA whereas the progress curve of the overall PRODH–
P5CDH reaction of EcRHH–RcPutA has no observable lag phase
consistent with a substrate channelling mechanism as shown re-
cently for RcPutA [29]. The SAXS analysis shows that although
EcRHH–RcPutA and EcPutA have the same shape and quatern-
ary structure, the chimaera is approximately 20 ˚A shorter in one
dimension. As a result, the catalytic lobes are closer together in
the EcRHH–RcPutA than in EcPutA. This was of interest to us
as the spacing of the catalytic lobes must be wide enough to al-
low the RHH domain to interact with DNA. In EcRHH–RcPutA,
the spacing is narrower relative to EcPutA, possibly restricting
the accessibility of the RHH domain to DNA. EcRHH–RcPutA,
however, exhibits DNA-binding similar to EcPutA indicating that
the spatial separation of the catalytic lobes is adequate for the
DNA binding activity of EcRHH–RcPutA. The lipid pull-down
assays show proline enhances EcRHH–RcPutA membrane bind-
ing consistent with the redox switching mechanism of EcPutA.
These results, along with the DNA binding activity, suggest that
RcPutA has been successfully converted into a trifunctional PutA
protein by adding the EcRHH domain.
Our findings suggest the trifunctionality of type C PutA de-
rives from a dimeric structure anchored by a RHH domain that
is sandwiched between two catalytic lobes. The spacing of the
catalytic lobes is likely critical to enable the RHH domain to ac-
cess DNA. Although the oligomeric state and catalytic properties
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Figure 8 Model of RcPutA from SAXS rigid body modelling [29]
(A) Model of RcPutA highlighting domain architecture and locations of
the active sites. The grey surface represents the substrate-channelling
tunnel. (B) Close-up view showing the predicted spatial proximity of the
PRODH active site and CTD β -flap.
of RcPutA were previously determined, the membrane binding
properties RcPutA were unstudied [29]. In the present study, we
showed that RcPutA displays enhanced membrane binding in
the presence of proline. Heretofore, this property was thought to
be exclusive to trifunctional PutAs. For example, the membrane-
binding affinity of the type A PutA from B. japonicum was shown
to be insensitive to proline [50]. The physiological rationale for
regulating RcPutA membrane interactions is not clear, as RcPutA
does not have a transcriptional repressor function. In R. capsu-
latus, putA expression is activated in response to proline by the
PRODH activator, PutR [51]. PutR contains a helix-turn-helix
motif and is a member of the Lrp/AsnC family of DNA binding
proteins [51]. Nevertheless, our results for RcPutA indicate that
type B PutAs contain at least some of the structural elements that
are responsible for functional switching.
The CTD may be an element of the functional switching ap-
paratus, since this domain is absent in type A PutAs and present
in types B and C PutAs. Recent studies of RcPutA suggested
that the CTD is a structural domain that couples the PRODH and
P5CDH domains, and facilitates P5CDH activity and substrate
channelling [29]. The data presented here furthermore implic-
ate the CTD in functional switching, since RcPutA-membrane
association was shown to be redox regulated, similar to trifunc-
tional PutAs, and this domain is missing in non-switching type A
PutAs. This role is consistent with our model of RcPutA showing
that the β-flap of the CTD approaches the second sphere of the
PRODH active site, contacting helices α8 and α5a of the PRODH
domain (Figure 8). This spatial relationship is potentially signi-
ficant because α8 contains several conserved residues that bind
the substrate proline and has been shown to shift by several ˚A
upon flavin reduction [31,52]. Furthermore, α5a directly contacts
the FAD and is a PutA-specific secondary structural element not
found in monofunctional PRODHs (Figure 8B). Thus, we suggest
that the CTD may be appropriately positioned to sense and trans-
duce conformational changes in the PRODH domain induced by
flavin reduction. Delineation of the membrane-binding region of
PutAs in future studies will be necessary to understand the po-
tential role of the CTD in functional switching and to identify
structural elements involved in reductive activation of PutA-lipid
binding.
AUTHOR CONTRIBUTION
Benjamin Arentson engineered and purified the EcRHH–RcPutA Chi-
maera. Benjamin Arentson, Erin Hayes and Weidong Zhu performed
the biochemical and biophysical characterization of the EcRHH–
RcPutA chimaera whereas Harkewal Singh performed the SAXS
analysis. Donald Becker and John Tanner coordinated the study
and wrote the manuscript. Benjamin Arentson and Harkewal Singh
also wrote parts of the manuscript. All authors have reviewed and
approve the manuscript.
ACKNOWLEDGEMENTS
We thank Kevin Dyer of the SIBYLS Mail-In SAXS Program for collect-
ing the SAXS data. X-ray scattering and diffraction technologies and
their applications to the determination of macromolecular shapes
and conformations at the SIBYLS beamline at the Advanced Light
Source, Lawrence Berkeley National Laboratory, are supported in
part by the DOE program Integrated Diffraction Analysis Technolo-
gies (IDAT) under Contract Number DE-AC02-05CH11231 with the
U.S. Department of Energy.
Funding
This work was supported by the National Institutes of Health [grant
numbers GM061068 and P30GM103335]; the National Science
Foundation [grant numbers DBI-0851747 and DBI-0619764]; and
the University of Nebraska Agricultural Research Division.
REFERENCES
1 Liang, X., Zhang, L., Natarajan, S.K. and Becker, D.F. (2013)
Proline mechanisms of stress survival. Antioxid. Redox Signal. 19,
998–1011 CrossRef PubMed
2 Szabados, L. and Savoure, A. (2010) Proline: a multifunctional
amino acid. Trends Plant Sci. 15, 89–97 CrossRef PubMed
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
9
B.W. Arentson and others
3 Wood, J.M., Bremer, E., Csonka, L.N., Kraemer, R., Poolman, B.,
van der Heide, T. and Smith, L.T. (2001) Osmosensing and
osmoregulatory compatible solute accumulation by bacteria.
Comp. Biochem. Physiol. A Mol. Integr. Physiol. 130, 437–460
CrossRef
4 Natarajan, S.K., Zhu, W., Liang, X., Zhang, L., Demers, A.J.,
Zimmerman, M.C., Simpson, M.A. and Becker, D.F. (2012) Proline
dehydrogenase is essential for proline protection against hydrogen
peroxide-induced cell death. Free Radic. Biol. Med. 53,
1181–1191 CrossRef PubMed
5 Phang, J.M., Liu, W. and Zabirnyk, O. (2010) Proline metabolism
and microenvironmental stress. Annu. Rev. Nutr. 30, 441–463
CrossRef PubMed
6 Liu, W., Le, A., Hancock, C., Lane, A.N., Dang, C.V., Fan, T.W.M.
and Phang, J.M. (2012) Reprogramming of proline and glutamine
metabolism contributes to the proliferative and metabolic
responses regulated by oncogenic transcription factor c-MYC. Proc.
Natl. Acad. Sci. U.S.A. 109, 8983–8988 CrossRef PubMed
7 Willis, A., Bender, H.U., Steel, G. and Valle, D. (2008) PRODH
variants and risk for schizophrenia. Amino Acids 35, 673–679
CrossRef PubMed
8 Chakravarti, A. (2002) A compelling genetic hypothesis for a
complex disease: PRODH2/DGCR6 variation leads to
schizophrenia susceptibility. Proc. Natl. Acad. Sci. U.S.A. 99,
4755–4756 CrossRef PubMed
9 Zarchi, O., Carmel, M., Avni, C., Attias, J., Frisch, A., Michaelovsky,
E., Patya, M., Green, T., Weinberger, R., Weizman, A. and Gothelf,
D. (2013) Schizophrenia-like neurophysiological abnormalities in
22q11.2 deletion syndrome and their association to COMT and
PRODH genotypes. J. Psychiatr. Res. 47, 1623–1629
CrossRef PubMed
10 Nakajima, K., Inatsu, S., Mizote, T., Nagata, Y., Aoyama, K.,
Fukuda, Y. and Nagata, K. (2008) Possible involvement of putA
gene in Helicobacter pylori colonization in the stomach and motility.
Biomed. Res. 29, 9–18 CrossRef PubMed
11 Krishnan, N., Doster, A.R., Duhamel, G.E. and Becker, D.F. (2008)
Characterization of a Helicobacter hepaticus putA mutant strain in
host colonization and oxidative stress. Infect. Immun. 76,
3037–3044 CrossRef PubMed
12 Lee, I.R., Lui, E.Y., Chow, E.W., Arras, S.D., Morrow, C.A. and
Fraser, J.A. (2013) Reactive oxygen species homeostasis and
virulence of the fungal pathogen Cryptococcus neoformans
requires an intact proline catabolism pathway. Genetics. 194,
421–433 CrossRef PubMed
13 Tanner, J.J. (2008) Structural biology of proline catabolism. Amino
Acids 35, 719–730 CrossRef PubMed
14 Singh, R.K. and Tanner, J.J. (2012) Unique structural features and
sequence motifs of proline utilization A (PutA). Front. Biosci.
(Landmark Ed). 17, 556–568 CrossRef PubMed
15 Zhou, Y., Larson, J.D., Bottoms, C.A., Arturo, E.C., Henzl, M.T.,
Jenkins, J.L., Nix, J.C., Becker, D.F. and Tanner, J.J. (2008)
Structural basis of the transcriptional regulation of the proline
utilization regulon by multifunctional PutA. J. Mol. Biol. 381,
174–188 CrossRef PubMed
16 Ostrovsky de Spicer, P. and Maloy, S. (1993) PutA protein, a
membrane-associated flavin dehydrogenase, acts as a
redox-dependent transcriptional regulator. Proc. Natl. Acad. Sci.
U.S.A. 90, 4295–4298 CrossRef PubMed
17 Becker, D.F. and Thomas, E.A. (2001) Redox properties of the PutA
protein from Escherichia coli and the influence of the flavin redox
state on PutA-DNA interactions. Biochemistry 40, 4714–4721
CrossRef PubMed
18 Wood, J.M. (1987) Membrane association of proline
dehydrogenase in Escherichia coli is redox dependent. Proc. Natl.
Acad. Sci. U.S.A. 84, 373–377 CrossRef PubMed
19 Becker, D.F., Zhu, W. and Moxley, M.A. (2011) Flavin redox
switching of protein functions. Antioxid. Redox Signal. 14,
1079–1091 CrossRef PubMed
20 Brown, E.D. and Wood, J.M. (1993) Conformational change and
membrane association of the PutA protein are coincident with
reduction of its FAD cofactor by proline. J. Biol. Chem. 268,
8972–8979 PubMed
21 Zhu, W. and Becker, D.F. (2003) Flavin redox state triggers
conformational changes in the PutA protein from Escherichia coli.
Biochemistry 42, 5469–5477 CrossRef PubMed
22 Zhang, W., Zhou, Y. and Becker, D.F. (2004) Regulation of
PutA-membrane associations by flavin adenine dinucleotide
reduction. Biochemistry 43, 13165–13174 CrossRef PubMed
23 Muro-Pastor, A.M., Ostrovsky, P. and Maloy, S. (1997) Regulation of
gene expression by repressor localization: biochemical evidence
that membrane and DNA binding by the PutA protein are mutually
exclusive. J. Bacteriol. 179, 2788–2791 PubMed
24 Gu, D., Zhou, Y., Kallhoff, V., Baban, B., Tanner, J.J. and Becker,
D.F. (2004) Identification and characterization of the DNA-binding
domain of the multifunctional PutA flavoenzyme. J. Biol. Chem.
279, 31171–31176 CrossRef PubMed
25 Larson, J.D., Jenkins, J.L., Schuermann, J.P., Zhou, Y., Becker, D.F.
and Tanner, J.J. (2006) Crystal structures of the DNA-binding
domain of Escherichia coli proline utilization A flavoprotein and
analysis of the role of Lys9 in DNA recognition. Protein Sci. 15,
2630–2641 CrossRef PubMed
26 Zhu, W., Haile, A.M., Singh, R.K., Larson, J.D., Smithen, D., Chan,
J.Y., Tanner, J.J. and Becker, D.F. (2013) Involvement of the
beta3-alpha3 loop of the proline dehydrogenase domain in
allosteric regulation of membrane association of proline utilization
A. Biochemistry 52, 4482–4491 CrossRef PubMed
27 Srivastava, D., Zhu, W., Johnson, Jr, W.H., Whitman, C.P., Becker,
D.F. and Tanner, J.J. (2010) The structure of the proline utilization
a proline dehydrogenase domain inactivated by N-propargylglycine
provides insight into conformational changes induced by substrate
binding and flavin reduction. Biochemistry 49, 560–569
CrossRef PubMed
28 Tanner, J.J. and Becker, D.F. (2013) PutA and proline metabolism.
In Handbook of Flavoproteins (Hille, R., Miller, S.M. and Palfey, B.,
eds), pp. 31–56, Walter de Gruyter, Boston
29 Luo, M., Christgen, S., Sanyal, N., Arentson, B.W., Becker, D.F. and
Tanner, J.J. (2014) Evidence that the C-terminal domain of a Type B
PutA protein contributes to aldehyde dehydrogenase activity and
substrate channeling. Biochemistry 53, 5661–5673
CrossRef PubMed
30 Srivastava, D., Schuermann, J.P., White, T.A., Krishnan, N., Sanyal,
N., Hura, G.L., Tan, A., Henzl, M.T., Becker, D.F. and Tanner, J.J.
(2010) Crystal structure of the bifunctional proline utilization A
flavoenzyme from Bradyrhizobium japonicum. Proc. Natl. Acad. Sci.
U.S.A. 107, 2878–2883 CrossRef PubMed
31 Singh, H., Arentson, B.W., Becker, D.F. and Tanner, J.J. (2014)
Structures of the PutA peripheral membrane flavoenzyme reveal a
dynamic substrate-channeling tunnel and the quinone-binding site.
Proc. Natl. Acad. Sci. U.S.A. 111, 3389–3394 CrossRef PubMed
32 Zhang, W., Zhang, M., Zhu, W., Zhou, Y., Wanduragala, S.,
Rewinkel, D., Tanner, J.J. and Becker, D.F. (2007) Redox-induced
changes in flavin structure and roles of flavin N(5) and the ribityl
2’-OH group in regulating PutA–membrane binding. Biochemistry
46, 483–491 CrossRef PubMed
33 Moxley, M.A., Tanner, J.J. and Becker, D.F. (2011) Steady-state
kinetic mechanism of the proline: ubiquinone oxidoreductase
activity of proline utilization A (PutA) from Escherichia coli. Arch.
Biochem. Biophys. 516, 113–120 CrossRef PubMed
34 Michaelis, L. and Menten, M.L. (1913) Die Kinetik der
Invertinwirkung. Biochim. Z. 49, 333–369
35 Hura, G.L., Menon, A.L., Hammel, M., Rambo, R.P., Poole, II, F.L.,
Tsutakawa, S.E., Jenney, Jr, F.E., Classen, S., Frankel, K.A.,
Hopkins, R.C. et al. (2009) Robust, high-throughput solution
structural analyses by small angle X-ray scattering (SAXS). Nat.
Methods 6, 606–612 CrossRef PubMed
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10 c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
Chimaeric PutA enzyme
36 Classen, S., Hura, G.L., Holton, J.M., Rambo, R.P., Rodic, I.,
McGuire, P.J., Dyer, K., Hammel, M., Meigs, G., Frankel, K.A. and
Tainer, J.A. (2013) Implementation and performance of SIBYLS: a
dual endstation small-angle X-ray scattering and macromolecular
crystallography beamline at the advanced light source. J. Appl.
Crystallogr. 46, 1–13 CrossRef PubMed
37 Konarev, P.V., Volkov, V.V., Sokolova, A.V., Koch, M.H.J. and
Svergun, D.I. (2003) PRIMUS: a Windows PC-based system for
small-angle scattering data analysis. J. Appl. Crystallogr. 36,
1277–1282 CrossRef
38 Svergun, D. (1992) Determination of the regularization parameter
in indirect-transform methods using perceptual criteria. J. Appl.
Crystallogr. 25, 495–503 CrossRef
39 Rambo, R.P. and Tainer, J.A. (2013) Accurate assessment of mass,
models and resolution by small-angle scattering. Nature 496,
477–481 CrossRef PubMed
40 Luo, M., Singh, R.K. and Tanner, J.J. (2013) Structural
determinants of oligomerization of delta(1)-pyrroline-5-carboxylate
dehydrogenase: identification of a hexamerization hot spot. J. Mol.
Biol. 425, 3106–3120 CrossRef PubMed
41 Volkov, V.V. and Svergun, D.I. (2003) Uniqueness of ab initio shape
determination in small-angle scattering. J. Appl. Crystallogr. 36,
860–864 CrossRef
42 Wriggers, W. (2010) Using Situs for the integration of
multi-resolution structures. Biophys. Rev. 2, 21–27
CrossRef PubMed
43 Kozin, M.B. and Svergun, D.I. (2001) Automated matching of high-
and low-resolution structural models. J. Appl. Crystallogr. 34,
33–41 CrossRef
44 Valentini, E., Kikhney, A.G., Previtali, G., Jeffries, C.M. and
Svergun, D.I. (2015) SASBDB, a repository for biological
small-angle scattering data. Nucleic Acids Res. 43, D357–D363
CrossRef PubMed
45 Moxley, M.A., Sanyal, N., Krishnan, N., Tanner, J.J. and Becker, D.F.
(2014) Evidence for hysteretic substrate channeling in the proline
dehydrogenase and Delta1-pyrroline-5-carboxylate dehydrogenase
coupled reaction of proline utilization A (PutA). J. Biol. Chem. 289,
3639–3651 CrossRef PubMed
46 Singh, R.K., Larson, J.D., Zhu, W., Rambo, R.P., Hura, G.L., Becker,
D.F. and Tanner, J.J. (2011) Small-angle X-ray scattering studies of
the oligomeric state and quaternary structure of the trifunctional
proline utilization A (PutA) flavoprotein from Escherichia coli. J. Biol.
Chem. 286, 43144–43153 CrossRef PubMed
47 Putnam, C.D., Hammel, M., Hura, G.L. and Tainer, J.A. (2007) X-ray
solution scattering (SAXS) combined with crystallography and
computation: defining accurate macromolecular structures,
conformations and assemblies in solution. Q. Rev. Biophys. 40,
191–285 CrossRef PubMed
48 Rambo, R.P. and Tainer, J.A. (2010) Bridging the solution divide:
comprehensive structural analyses of dynamic RNA, DNA, and
protein assemblies by small-angle X-ray scattering. Curr. Opin.
Struct. Biol. 20, 128–137 CrossRef PubMed
49 Rambo, R.P. and Tainer, J.A. (2011) Characterizing flexible and
instrinsically unstructured biological macromolecules by SAS using
the porod-debye law. Biopolymers 95, 559–571
CrossRef PubMed
50 Zhang, W., Krishnan, N. and Becker, D.F. (2006) Kinetic and
thermodynamic analysis of Bradyrhizobium japonicum
PutA-membrane associations. Arch. Biochem. Biophys. 445,
174–183 CrossRef PubMed
51 Keuntje, B., Masepohl, B. and Klipp, W. (1995) Expression of the
putA gene encoding proline dehydrogenase from Rhodobacter
capsulatus is independent of NtrC regulation but requires an
Lrp-like activator protein. J. Bacteriol. 177, 6432–6439
PubMed
52 Luo, M., Arentson, B.W., Srivastava, D., Becker, D.F. and Tanner,
J.J. (2012) Crystal structures and kinetics of monofunctional
proline dehydrogenase provide insight into substrate recognition
and conformational changes associated with flavin reduction and
product release. Biochemistry 51, 10099–10108
CrossRef PubMed
53 Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S.,
Greenblatt, D.M., Meng, E.C. and Ferrin, T.E. (2004) UCSF
Chimera–a visualization system for exploratory research and
analysis. J. Comput. Chem. 25, 1605–1612
CrossRef PubMed
Received 29 September 2016/5 October 2016; accepted 14 October 2016
Accepted Manuscript online 14 October 2016, doi 10.1042/BSR20160435
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
11
